Back to NewsPublished: 12 Feb 2026Download AppJoin TelegramWhy OneSource’s Saudi GLP‑1 Win Could Redefine Your Pharma Bet#OneSource Specialty Pharma#GLP-1#Semaglutide#Hikma Pharmaceuticals#CDMO#Emerging Markets#Pharma InvestmentDownload AppJoin CommunityShare Article